Our Products

Everolimus Tablets 5 mg is a medication used to treat certain types of cancer, including advanced renal cell carcinoma (kidney cancer), neuroendocrine tumors, and breast cancer. It is also used in preventing organ rejection in transplant patients. Everolimus is an mTOR (mechanistic target of rapamycin) inhibitor, which works by blocking the mTOR pathway, a key regulator of cell growth, proliferation, and survival. By inhibiting mTOR, Everolimus helps slow the growth of cancer cells and suppresses the immune system in transplant patients.

The typical dosage is 5 mg, taken once daily, as prescribed by a healthcare provider. Common side effects include mouth ulcers, diarrhea, fatigue, and risk of infections due to immune suppression. Regular monitoring of blood counts, liver function, and kidney function is recommended during treatment.